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Background: Although malaria is preventable and treatable, it still claims 660,000 lives every year globally with
children under five years of age having the highest burden. In Zambia, malaria rapid diagnostic tests (RDTs) that
only detect Plasmodium falciparum are the main confirmatory means for malaria diagnosis in most health facilities
without microscopy services. As a consequence of this P. falciparum species diagnostic approach, non-falciparum
malaria is not only under-diagnosed but entirely missed, thereby making the exact disease burden unknown. We
thus investigated the prevalence of various Plasmodium spp. and associated burden of infection in selected
communities in Zambia.
Methods: Data from two malaria hyper-endemic provinces (Eastern and Luapula) of the 2012 National Malaria
Indicator Survey (MIS), conducted between April and May 2012, were used. The MIS is a nationally representative,
two-stage cluster survey conducted to coincide with the end of the malaria transmission season. Social, behavioural
and background information were collected from households as part of the survey. Thick blood smears, RDTs and
dried blood spots (DBS) were collected from children below six years of age. Slides were stained using Giemsa and
examined by microscopy while polymerase chain reaction (PCR) was used to analyse the DBS for malaria Plasmodium
spp. Multivariate logistic regression was employed to examine the association between background factors and malaria.
Results: Overall, 873 children younger than six years of age were surveyed. The overall prevalence of Plasmodium
spp. by PCR was 54.3% (95% CI 51–57.6%). Of the total Plasmodium isolates, 88% were P. falciparum, 10.6% were
mixed infections and 1.4% were non-falciparum mono infections. Among the mixed infections, the majority were
a combination of P. falciparum and P. malariae (6.5% of all mixed infections). Children two years and older
(2–5 years) had three-fold higher risk of mixed malaria infections (aOR 2.8 CI 1.31–5.69) than children younger
than two years of age.
Conclusion: The high prevalence of mixed Plasmodium spp. infections in this population stresses review of the
current malaria RDT diagnostic approaches. The observed less incidence of mixed infections in children under
two years of age compared to their older two-to-five-year-old counterparts is probably due to the protective
maternal passive immunity, among other factors, in that age group.
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Malaria remains a significant public health problem in
many countries throughout the world, especially in sub-
Saharan Africa, despite being preventable and treatable
[1]. In 2010, the World Health Organisation (WHO) es-
timated approximately 219 million malaria cases and
660,000 deaths, with 90% of the deaths occurring in
Africa [2]. Approximately 40% of the world’s population
lives in areas that have some risk of malaria [3]. The dis-
tribution of Plasmodium spp. is not clearly known,
although estimates of the global distribution of Plasmo-
dium falciparum and P. vivax, the most predominant
malaria Plasmodium spp., are widely cited [4-6]. Mueller
et al [6] reported that the global numbers for P. malariae
and P. ovale are unknown and the burdens of P. ovale and
P. malariae are even more underrepresented in surveys
where microscopy is employed since there are morpho-
logical resemblances between P. ovale and P. vivax.
Non-falciparum malaria may be present in Zambia
given that P. malariae cases are routinely reported and
the anecdotal prevalence is estimated to be approxi-
mately 2%. Furthermore, Blossom et al. [7] described a
case of a 23-year-old woman who, after a trip to Zambia,
presented with a prolonged illness characterized by fe-
vers of up to 38.1°C and fatigue. Malaria smear and anti-
body tests were negative but polymerase chain reaction
(PCR) showed the presence of P. vivax. Low prevalence
of P. vivax on the African continent is attributed to high
prevalence of the Duffy negative factor, a gene inherent
among the majority of indigenous Africans that is other-
wise responsible for refractoriness to P. vivax [8-10].
Infections with more than one Plasmodium spp. are
possible and are called mixed infection. Mixed malaria
species infections are often not recognized or are under-
estimated by microscopists [11,12]. In Asia, surveys usu-
ally report that greater than 2% of infections are mixed,
whereas therapeutic studies in P. vivax or P. falciparum
malaria have demonstrated a high prevalence of up to
30% of mixed infections. Other malaria species have also
been reported during convalescence, suggesting covert co-
infections [13]. In Manhica District of Mozambique, shar-
ing borders with Zambia’s Eastern Province, P. malariae
and P. ovale occurred almost exclusively in mixed infec-
tions [14]. This situation may be similar to the Zambian
scenario as the geography and climatic factors are similar.
Although this has not been documented, Zambian tech-
nologists and scientists often see and report a few cases of
mixed infection routinely.
The Zambia National Malaria Control Programme
(NMCP) has been at the forefront of scaling up malaria in-
terventions over the past decade, including the early adop-
tion of artemisinin-based combination therapy and use of
rapid diagnostics tests (RDTs) for clinical management of
malaria. The 2011-2015 National Malaria Strategic Plancalls for the creation of malaria free zones during its
current five-year span. Therefore, understanding the
extent to which current tools are able to achieve these
goals is important. It follows that further understanding of
the distribution of local malaria parasite species is import-
ant for developing appropriate preventive as well as diag-
nostic and treatment option. Unfortunately, many malaria-
endemic countries, especially in sub-Saharan Africa, are
just beginning to understand the relative levels of prevalent
malaria parasite species as malaria control programmes
begin to expand in the pursuit of malaria elimination. With
the anecdotal evidence that P. falciparum is the pre-
dominant cause of malaria (98%), Zambia has relied on
the exclusive use of histidine-rich protein 2 (HRP2) or
P. falciparum-based antigen detection RDTs. [15].
This study sought to determine the proportion of mixed
Plasmodium spp. causing malaria in Eastern and Luapula
provinces of Zambia using stored samples from the Mal-
aria Indicator Survey of 2012, conducted to monitor the
progress of malaria control implementation efforts by the
National Malaria Control Program (NMCP). This informa-
tion is necessary to guide and inform malaria management
and control strategies as well as provide country-specific




Data and samples from MIS conducted between April
and May 2012 for two provinces in Zambia were uti-
lized. MIS’s have been conducted biannually since 2006
and are used by the NMCP to evaluate progress in scal-
ing up malaria control interventions and to monitor
levels of malaria parasite prevalence among children
aged five years and younger [16]. The 2012 MIS was the
fourth in the series, the first being in 2006, the second in
2008 and the third in 2010. Details of MIS findings are
reported elsewhere [17-19].
Study samples from children under six years of age were
used from two provinces, Eastern and Luapula. These two
provinces were noted to be hyper-endemic for malaria,
with the highest levels of malaria parasite prevalence
among sampled children during the 2012 MIS study [16].
For this study, all records with complete information on
relevant socio-demographic characteristics of household
members as well as verifiable records of RDT results,
blood smears and dried blood spots (DBS) for all children
below six years of age were included in the study. The
RDTs used in this survey were HRP2 antigen-based SD
Bioline (Standard Diagnostics, INC) RDTs.
Polymerase chain reaction (PCR) protocol
Identification of Plasmodium spp. was performed using
nested PCR, performed at the National Malaria Control
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random samples at Tulane University. DNA was ex-
tracted using the chelex method [20] and the nested
PCR assay was adapted from Nsobya et al [21].
The protocol was designed such that in the first reac-
tion a conserved region for the four species was ampli-
fied (P. falciparum, P. vivax, P. ovale and P. malariae).
In the second reaction, different primers were run for
the four species separately. The band sizes of the prod-
ucts were as follows: P. falciparum 205 bp, P. malariae
140 bp, P. ovale 800 bp and P. vivax 120 bp.
The PCR mixture for the first reaction contained
12.5 μL of a 2X master mix containing Taq buffer (10 mM
Tris–HCl, pH 8.3, 50 mM KCL, 1.5 mM MgCl2), 200 μM
of each dNTP 2.5 units of Taq DNA polymerase, PCR
primers (10 μM of rPLUf and rPLUr) and 5 μL of DNA
template and water in a final volume of 25 μL. In the sec-
ond reaction, the same master mix was used but with dif-
ferent primer concentration (10 μM of each of the
species-specific primers in separate tubes), 2 μL DNA
template from the first reaction in a 25 μL reaction vol-
ume. The PCR was run in a gene Amp PCR system 9700
(Applied Biosystems thermocycler, Foster City CA, USA)
under the following conditions: the first reaction had de-
naturation at 94°C for one minute followed by 35 cycles at
94°C for one minute, 58°C for two minutes and 72°C for
five minutes; the second reaction (with four tubes for each
primer) had denaturation at 94°C for one minute, followed
by 30 cycles at 94°C for one minute, 58°C for two minutes
and 72°C for five minutes. The final cycle was followed by
an extension time of five minutes at 72°C. A 2% agarose
gel stained with ethidium bromide was run for visualisa-
tion of the PCR product [20].
Data and statistical analysis
Demographic and laboratory data of the participants’ re-
cords was analysed with Stata version 11 (College Station,
Texas, USA) with the cluster effect accounted for in the
analyses. The Mantel-Haenszel chi square test (x2), and in
some cases Fisher’s exact tests for proportions, were used
to test for independence. Multivariate logistic regression
was used to examine the association between background
factors with malaria between comparable categories. The
distribution of age as a continuous variable conformed to
normality as assessed by probability plots.
Ethical approval
The 2012 MIS survey protocol received clearance by the
University of Zambia Biomedical Research Ethics Com-
mittee as a continuation of the 2006, 2008 and 2010 sur-
veys. The reference for the Malaria Indicator Survey it was
002-03-12. In addition, participation in the MIS question-
naires and malaria testing were based on informed con-
sent from their respective parents or guardians as allchildren in the survey were below six years of age. Respon-
dents were counselled and informed that the testing was
purely for research purposes and was to be handled
anonymously. However, respondents were informed of
their test results and available treatment was provided
based on national malaria treatment standard care guide-
lines. For this study of mixed infections, additional ap-




The de facto eligible population comprised only children
younger than six years who had complete records and
were tested for malaria infection. Thus, only 873 chil-
dren were included in the final analysis. Of these chil-
dren, 47% were male and 53% were female. There were
504 (57.7%) children from Eastern Province and 369
(42.3%) from Luapula Province. Larger proportions
(95.7%) of these children were classified according to the
national census as living in rural clusters, with only 4.4%
living in an urban cluster (Table 1).
Prevalence
Overall, the prevalence of malaria infection using PCR
was 54.3% (95% CI 51–57.6%) (Figure 1), with Luapula
Province accounting for a higher burden than Eastern
Province (55.6% vs. 52.6%, respectively). From the total
positive samples, the predominant species was P. falcip-
arum (88.3%) with 11.6% due to non-falciparum species
and 10.3% were mixed infections (Table 2). The observed
mixed infections were in five categories or combinations.
Most children were found to have a combination of P .fal-
ciparum and P. malariae (6.5%); P. falciparum, P. malar-
iae and P. ovale (6%); and P. falciparum and P. ovale
(2.1%). The combinations of P. falciparum, P. malariae
and P. vivax (0.2%), and P. falciparum and P. vivax (0.2%)
were rare (Table 2).
Factors associated with mixed plasmodium infections
Assessment of factors associated with mixed Plasmo-
dium infections (Table 3) showed an association between
mixed infections with province and age of the child.
Children older than two years of age were almost three
times more likely to have mixed malaria infections than
children younger than two years of age (aOR 2.8, 95%
CI, 1.31–5.69). This association was stronger in Luapula
province where likelihood of children having mixed in-
fection was four-fold higher (aOR 4.2, 95% CI 2.00–8.73)
than in children residing in Eastern Province.
Discussion
The study showed a significantly high prevalence of mal-
aria in two provinces of Zambia, demonstrating for the
Table 1 Socio-demographic factors for the study
participants in the Luapula and Northern Provinces in
Zambia
Total number of children test =873
Characteristics N % (CI)
Gender
Male 410 47.0 (43.6–50.2)
Female 463 53.0 (49.7–56.4)
Age of children
<1 year 132 15.1 (12.7–17.5)
1 yr 144 16.5(14.0–19.0)
2 yrs 151 17.3(14.8–19.8)
3 yrs 178 20.4(17.7–23.1)
4 yrs 156 17.9 (15.3–20.4)
5 yrs 112 12.8(10.6–15.1)
Province
Eastern 504 57.7 (54.4–61.0)
Luapula 369 42.3 (39.0–45.5)
Residence
Urban 38 4.4 (3.0–5.7)
Rural 835 95.7 (94.3–97.0)
Age of Mother 47 6.0 (4.3–7.7)
15–19 207 26.4 (23.3–29.5)
20–24 203 25.9 (23.0–28.9)
25–29 254 32.4 (29.1–35.6)
30–39 74 9.4 (7.4–11.5)
School level of mother
Low-Below grade 5 420 53.5 (50.0–57.0)
High- Grade 5 and above 365 46.5 (43.0–50.0)
Table 2 Differential overall prevalence of mixed and
mono infections in Eastern and Luapula Provinces
combined




Pf + Pm + Po 6 1.3
Pf + Pm + Pv 1 0.2
Pf + Pm 31 6.5
Pf + Po 10 2.1
Pf + Pv 1 0.2
Total 474 100
Total combinations 55 10.3*
Note: All positives is the n = 474, *10.3%, is the percentage for all mixed
infection combination.
Key: Pf-Plasmodium falciparum; Pm- Plasmodium malariae; Po- Plasmodium
ovale; Pv- Plasmodium vivax.
Table 3 Results logistic regression model for malaria
mixed infection for the study participants from Luapula
and Northern Provinces in Zambia
Malaria mixed parasites infection n = 873
Characteristic Prevalence aOR 95% CI
Age in years
0 > 2 2.8% 1
2–5 8.3% 2.80 1.31–5.69
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major Plasmodium species in the studied population. Al-
though the malaria prevalence is predominantly due to P.
falciparum, the prevalence of non-falciparum mixed in-
fections was significantly higher than previously reported.Figure 1 Prevalence of Plasmodium species infections in Eastern
and Luapula provinces in Zambia.This high prevalence partly explains why malaria still re-
mains one of the leading causes of morbidity and mortality
in Zambia despite the current control and management
measures. The high prevalence of malaria due to all four
species and in both mono and mixed infections patterns
clearly reveals not just the presence of non-falciparum
species but also the dynamic and evolving nature of the
malaria epidemic. The 11.6% is actually close to the anec-
dotal level of non-falciparum-only infections known, butGender
Male 46.4% 1
Female 53.6% 0.9 0.50–1.88
Age of the mother in years
15–24 3.5 % 1
25–39 5.3 % 1.4 0.61–3.13
40–49 8.1 % 2.6 0.83–7.84
Province
Eastern 3.0 % 1
Luapula 9.2 % 4.2 2.00–8.73
Ownership of Mosquito net
No 58.0% 1
Yes 53.4% 0.5 0.14–1.79
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cant contribution of the total infection prevalence than
previously considered. These findings suggest that there
is need for continued monitoring of non-falciparum in-
fection prevalence in this population so as to decide
when species-specific RDTs should be introduced for
diagnostic purposes. The species-specific diagnosis will
be important when the prevalence of malaria in this
population reduces and as the country moves towards
malaria elimination. In addition, Coartem, the first-line
treatment drug in Zambia, does not clear Plasmodium
hypnozoites and radical treatment with primaquine, ef-
fective against hypnozoites may play an important role
in the control and eventually elimination of vivax and
ovale malaria, and malaria consequently [22].
Differential species burden patterns observed were not
surprising as similar observations have been reported
elsewhere [14,23]. However, the fact that non-falciparum
malaria cases were present in the study population ne-
cessitates the need to have diagnostic tools or ap-
proaches at the national level that should facilitate the
detection of such non-falciparum malaria cases. While it
should not necessarily be the primary diagnostic tool,
diagnostic approaches that have the capacity to further
investigate and detect non-falciparum malaria may be-
come important in future. For health facilities where mi-
croscopy services are present, there is a need to conduct
refresher courses for laboratory staff and microscopists
with an emphasis on Plasmodium species-wide micros-
copy so as to strengthen non-falciparum malaria diagnosis
as has been reported and advocated elsewhere [7,10,24].
Among the factors associated with mixed malaria
infections, age was found to be a predictor. This is in
agreement with a similar study by Guerra-Neira et al
[25] who reported an inverse correlation between of age
and multiplicity of Plasmodium infection, with children
under five years of age having higher frequency of mixed
Plasmodium malaria compared to individuals older than
five years of age. Children younger than two years in our
study were found to be less likely to have mixed malaria
infections compared to those aged from two to five
years. This could be partly explained by the maternally
derived antibodies believed to offer protection from in-
fections. Riley et al reported that neonates and infants
are relatively protected from clinical malaria, although
the mechanism of the protection is not clearly under-
stood [26]. Indeed, the dynamics of immunity in neo-
nates, infants and toddlers is quite remarkable resulting
in variable susceptibility to infection [27,28]. Noteworthy
here is that, unlike the study by Guerra-Neira et al [25],
our study population was limited to children younger
than five years of age. In addition, these findings could
be attributed to the use of insecticide-treated nets
(ITNs) in that younger children tend to sleep underITNs as breast-feeding infants but, at the age of two-to-
three years, they are weaned off from breasting feeding
and may not sleep under an ITN.
Conclusion
This study reveals the presence of mixed infections in
two provinces of Zambia with an overall prevalence of
10.3%. The major factor associated with mixed infection
was the age of the child. This might call for repackaging
of control and management measures at national level.
The presence of non-falciparum infections might vary
with transmission patterns, demographic trends and
geographical contrasts. There is the need for these to be
monitored through a functional surveillance system so
as to understand the epidemiological profile. Given that
most of the non-falciparum malaria cases occur as
mixed infections, the use of HRP2-based RDTs can still
continue in health facilities but need to be strengthened
with improved and enhanced microscopy to facilitate de-
tection of the non-falciparum malaria cases. Finally,
there is a need for further studies to have a complete,
detailed profile and epidemiology of non-falciparum
species of malaria in the country, especially in the era of
malaria elimination activities in the country and region.
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